Literature DB >> 27647546

A comparison of adaptive iterative dose reduction 3D and filtered back projection in craniocervical CT angiography.

S Yu1, L Zhang2, J Zheng2, Y Xu2, Y Chen2, Z Song2.   

Abstract

AIM: To compare the effects of exposure parameters on image quality and radiation dose for craniocervical computed tomography angiography (CTA) using adaptive iterative dose reduction in three dimensions (AIDR 3D) and filtered back projection (FBP) algorithms.
MATERIALS AND METHODS: One hundred and eighty patients were divided into three groups; group A (120 kV, 300 mA, FBP), group B (100 kV, automatic mA, AIDR 3D) and group C (80kV, automatic mA, AIDR 3D). Image quality and radiation dose were evaluated for each group.
RESULTS: For both cervical and intracranial vessels, CT attenuation, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) were higher in the AIDR 3D groups. The difference in mean vascular noise was also statistically significant (p<0.001), with group B having the lowest value at 16.5±3.2 HU and group C having the highest at 19.1±2.9 HU. FBP reconstruction resulted in lower image-quality scores for the common carotid artery. Parenchymal image-quality scores also varied significantly different between groups with group C partially failing to meet the minimum standards for diagnostic use. For the middle cerebral artery, image-quality scores were significantly better in group A, although images from groups B and C also satisfied clinical diagnostic requirements. The image quality of the internal carotid artery was the best in group B. Image-quality scores between groups were not significantly different for the carotid sinus. Radiation doses in the groups using AIDR 3D were >70% lower than in the FBP group.
CONCLUSION: AIDR 3D (100 kV, automatic modulation) provides optimal image quality of vascular and parenchymal tissues at significantly lower radiation doses (mSV) than FBP in craniocervical CTA. For cases in which highly accurate parenchymal assessment is not required, the tube voltage can be lowered to 80 kV to further decrease radiation dose.
Copyright © 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27647546     DOI: 10.1016/j.crad.2016.08.004

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  Paper-based 3D printing of anthropomorphic CT phantoms: Feasibility of two construction techniques.

Authors:  Paul Jahnke; Stephan Schwarz; Marco Ziegert; Felix Benjamin Schwarz; Bernd Hamm; Michael Scheel
Journal:  Eur Radiol       Date:  2018-08-16       Impact factor: 5.315

Review 2.  Multimodality imaging assessment of endoleaks post-endovascular aortic repair.

Authors:  Sasan Partovi; Thomas Trischman; Vasileios Rafailidis; Suvranu Ganguli; Fabian Rengier; Harold Goerne; Prabhakar Rajiah; Daniel Staub; Indravadan J Patel; George Oliveira; Brian Ghoshhajra
Journal:  Br J Radiol       Date:  2018-05-02       Impact factor: 3.039

3.  Deep Learning-Based Reconstruction vs. Iterative Reconstruction for Quality of Low-Dose Head-and-Neck CT Angiography with Different Tube-Voltage Protocols in Emergency-Department Patients.

Authors:  Marc Lenfant; Pierre-Olivier Comby; Kevin Guillen; Felix Galissot; Karim Haioun; Anthony Thay; Olivier Chevallier; Frédéric Ricolfi; Romaric Loffroy
Journal:  Diagnostics (Basel)       Date:  2022-05-21

4.  Craniocervical computed tomography angiography with adaptive iterative dose reduction 3D algorithm and automatic tube current modulation in patients with different body mass indexes.

Authors:  Shujing Yu; Jing Zheng; Li Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

5.  Knowledge-based iterative model reconstruction: Comparative image quality with low tube voltage cerebral CT angiography.

Authors:  Xinrui Wang; Chengcheng Zhu; Jing Li; Andrew J Degnan; Tao Jiang; Jianping Lu
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.